In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

another patient at Erie Health who uses Lantus, an insulin pen. Last fall, after the 340B discount changed, she was quoted $490 at her pharmacy — the retail price for a box of insulin pens.

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

For its part, Sanofi released an announcement a day after Novo Nordisk, where it detailed how it would cut the list price of its Lantus product by 78%, as well as establishing a $35 cap on out-of ...

A 2020 law aimed partially at bringing down insulin prices allowed Newsom to negotiate the 10-year ... meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, ...

It sells products through independent distributors primarily in India.Sanofi India's products viz. Lantus Combiflam Amaryl and Allegra feature in the top 100 pharmaceutical brands in India. The ...

In the meantime, insulin prices have dropped nationally as a result ... meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate ...

A 2020 law aimed partially at bringing down insulin prices allowed Newsom to negotiate ... meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without ...